SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Julie Suk who wrote (178)12/13/1996 2:39:00 AM
From: Roger Cranwill   of 1762
 
Julie-I talked with Connie Matsui, IDEC's VP of Planning and Resource Development, today. She assures me that their building is their intended site for the full-scale production of C2B8. Genentech is contracted to co-produce C2B8 after the first two years-she says its spelled out in the annual report (something I'd forgotten). She says they're building their inventory now. I've called the company a couple of times, and am amazed at the availability of the officers of the company (I don't think I'd have that kind of luck calling Microsoft!) Roger
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News